Viemed Healthcare (VMD) Other financing activities (2024 - 2025)

Viemed Healthcare (VMD) reported Other financing activities of $115000.0 for Q4 2025, up 447.62% on a YoY basis from $21000.0 in Q4 2024, and up 447.62% quarter-over-quarter from $21000.0 in Q4 2024.

Viemed Healthcare (VMD) Other financing activities (2024 - 2025) Analysis & Trends

Viemed Healthcare has reported Other financing activities for 2 years, with the latest figure at $115000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities rose 447.62% year-over-year to $115000.0; the trailing twelve-month figure through Dec 2025 stood at $156000.0 (up 280.49% YoY), and the FY2025 full-year result was $115000.0, down 40.1% from the prior year.
  • Other financing activities for Q4 2025 stood at $115000.0, up from $21000.0 in the prior quarter.
  • The five-year high for Other financing activities was $115000.0 in Q4 2025, with the low at $20000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Viemed Healthcare 410.03 Mn 402.20 Mn 42.83 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 115,000.00
Dec 31, 2025 115,000.00
Dec 31, 2024 21,000.00
Dec 31, 2024 21,000.00
Sep 30, 2024 20,000.00
Sep 30, 2024 20,000.00